Cartesian Therapeutics

9.32
-0.78
-7.72%
RNAC
高 10.27开 10.14量 73044股总市值 2.42亿
低 9.31换 0.28%额 69.94万市盈TTM 亏损
分时
5日
日K
周K
月K
季K
年K
  • MA
  • BOLL
  • 成交量
  • MACD
  • KDJ
  • RSI
  • WR
  • BIAS
  • CCI
  • PSY
讨论
资讯
公告
资料
财务
相关
用户头像
Cartesian Therapeutics(RNAC)
10-08 19:05  
$Cartesian Therapeutics(RNAC)$ 8-K Current report, item 5.02 Accession Number: 0001453687-25-000104  Act: 34  Size: 149 KB 网页链接
用户头像
Cartesian Therapeutics(RNAC)
08-07 19:15  
$Cartesian Therapeutics(RNAC)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001453687-25-000098  Act: 34  Size: 1 MB 网页链接
用户头像
Cartesian Therapeutics(RNAC)
08-07 19:15  
$Cartesian Therapeutics(RNAC)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001453687-25-000099  Act: 34  Size: 8 MB 网页链接
用户头像
Cartesian Therapeutics(RNAC)
06-16 19:15  
$Cartesian Therapeutics(RNAC)$ 8-K Current report, item 5.07 Accession Number: 0001453687-25-000093  Act: 34  Size: 154 KB 网页链接
用户头像
Cartesian Therapeutics(RNAC)
05-30 19:05  
$Cartesian Therapeutics(RNAC)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001453687-25-000091  Act: 34  Size: 1 MB 网页链接
用户头像
Cartesian Therapeutics(RNAC)
05-15 04:25  
$Cartesian Therapeutics(RNAC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001453687-25-000089  Size: 7 KB 网页链接
用户头像
Cartesian Therapeutics(RNAC)
05-08 19:15  
$Cartesian Therapeutics(RNAC)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001453687-25-000085  Act: 34  Size: 8 MB 网页链接
用户头像
Cartesian Therapeutics(RNAC)
05-08 19:15  
$Cartesian Therapeutics(RNAC)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001453687-25-000087  Act: 33  Size: 115 KB 网页链接
用户头像
Cartesian Therapeutics(RNAC)
05-08 19:05  
$Cartesian Therapeutics(RNAC)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001453687-25-000084  Act: 34  Size: 1 MB 网页链接
用户头像
Cartesian Therapeutics(RNAC)
04-29 20:08  
$Cartesian Therapeutics(RNAC)$ 8-K Current report, item 5.02 Accession Number: 0001453687-25-000077  Act: 34  Size: 151 KB 网页链接
用户头像
Cartesian Therapeutics(RNAC)
04-29 04:45  
$Cartesian Therapeutics(RNAC)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001453687-25-000074  Act: 34  Size: 1 MB 网页链接
用户头像
Cartesian Therapeutics(RNAC)
04-29 04:45  
$Cartesian Therapeutics(RNAC)$ DEF 14A Other definitive proxy statements Accession Number: 0001453687-25-000075  Act: 34  Size: 6 MB 网页链接
用户头像
Cartesian Therapeutics(RNAC)
04-26 03:05  
$Cartesian Therapeutics(RNAC)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0000019617-25-000398  Act: 34  Size: 6 KB 网页链接
用户头像
Cartesian Therapeutics(RNAC)
04-08 19:15  
$Cartesian Therapeutics(RNAC)$ 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0001453687-25-000064  Act: 34  Size: 5 MB 网页链接
用户头像
Cartesian Therapeutics(RNAC)
03-21 07:55  
$Cartesian Therapeutics(RNAC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001453687-25-000062  Size: 10 KB 网页链接
用户头像
Cartesian Therapeutics(RNAC)
03-13 19:15  
$Cartesian Therapeutics(RNAC)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001453687-25-000060  Act: 34  Size: 17 MB 网页链接
用户头像
Cartesian Therapeutics(RNAC)
03-13 19:05  
$Cartesian Therapeutics(RNAC)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001453687-25-000059  Act: 34  Size: 1 MB 网页链接
用户头像
Cartesian Therapeutics(RNAC)
03-03 20:05  
$Cartesian Therapeutics(RNAC)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001453687-25-000054  Act: 34  Size: 2 MB 网页链接
用户头像
Cartesian Therapeutics(RNAC)
02-12 22:35  
$Cartesian Therapeutics(RNAC)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0000315066-25-000839  Act: 34  Size: 11 KB 网页链接
用户头像
Cartesian Therapeutics(RNAC)
01-27 20:05  
$Cartesian(RNAC)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001453687-25-000050  Act: 34  Size: 1 MB 网页链接